A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Lipid-Modifying Effect and Tolerability of MK-1903 in Patients with Dyslipidemia
100 项与 MSD Finland Oy 相关的临床结果
0 项与 MSD Finland Oy 相关的专利(医药)
100 项与 MSD Finland Oy 相关的药物交易
100 项与 MSD Finland Oy 相关的转化医学